![Coronado Biosciences logo](/news-release/logo/213560/0/213560.jpg?lastModified=12%2F09%2F2016%2023%3A47%3A03&size=2)
Coronado Biosciences to Present at the Citi 2012 Global Health Care Conference
February 23, 2012 06:59 ET
|
Coronado Biosciences
BURLINGTON, Mass., Feb. 23, 2012 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of...
![Coronado Biosciences logo](/news-release/logo/213560/0/213560.jpg?lastModified=12%2F09%2F2016%2023%3A47%3A03&size=2)
Coronado Biosciences Appoints Lucy Lu, M.D. as Executive Vice President and Chief Financial Officer
February 22, 2012 16:01 ET
|
Coronado Biosciences
BURLINGTON, Mass., Feb. 22, 2012 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of...
![Coronado Biosciences logo](/news-release/logo/213560/0/213560.jpg?lastModified=12%2F09%2F2016%2023%3A47%3A03&size=2)
Coronado Biosciences Announces IND Submission for CNDO-109 for the Treatment of Relapsed Acute Myeloid Leukemia
February 14, 2012 06:59 ET
|
Coronado Biosciences
BURLINGTON, Mass., Feb. 14, 2012 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of...
![Coronado Biosciences logo](/news-release/logo/213560/0/213560.jpg?lastModified=12%2F09%2F2016%2023%3A47%3A03&size=2)
Coronado Biosciences to Present at the Leerink Swann 2012 Global Healthcare Conference
February 13, 2012 07:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., Feb. 13, 2012 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of...
![Coronado Biosciences logo](/news-release/logo/213560/0/213560.jpg?lastModified=12%2F09%2F2016%2023%3A47%3A03&size=2)
Coronado Biosciences to Present at 30th Annual JP Morgan Healthcare Conference
January 12, 2012 07:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., Jan. 12, 2012 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of...
![Coronado Biosciences logo](/news-release/logo/213560/0/213560.jpg?lastModified=12%2F09%2F2016%2023%3A47%3A03&size=2)
Coronado Biosciences to Present at the Biotech Showcase 2012 Conference
January 06, 2012 08:42 ET
|
Coronado Biosciences
BURLINGTON, Mass., Jan. 6, 2012 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of...
![Coronado Biosciences logo](/news-release/logo/213560/0/213560.jpg?lastModified=12%2F09%2F2016%2023%3A47%3A03&size=2)
Coronado Biosciences Signs Binding Terms of Agreement to Enter Into Collaboration for Development of CNDO-201 for Crohn's Disease With Dr. Falk Pharma and OvaMed
December 22, 2011 14:00 ET
|
Coronado Biosciences
BURLINGTON, Mass., Dec. 22, 2011 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of...
![Coronado Biosciences logo](/news-release/logo/213560/0/213560.jpg?lastModified=12%2F09%2F2016%2023%3A47%3A03&size=2)
Coronado Biosciences Appoints Karin Hehenberger, M.D., Ph.D. as Senior Vice President of Scientific Affairs
December 20, 2011 07:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., Dec. 20, 2011 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc., (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment...
![Coronado Biosciences logo](/news-release/logo/213560/0/213560.jpg?lastModified=12%2F09%2F2016%2023%3A47%3A03&size=2)
Coronado Biosciences Approved for Listing on NASDAQ
December 15, 2011 14:14 ET
|
Coronado Biosciences
BURLINGTON, Mass., Dec. 15, 2011 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc., (OTCBB:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of...
![Coronado Biosciences logo](/news-release/logo/213560/0/213560.jpg?lastModified=12%2F09%2F2016%2023%3A47%3A03&size=2)
Coronado Biosciences is Granted First Patent for CNDO-109
December 14, 2011 07:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., Dec. 14, 2011 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc., (OTCBB:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of...